http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109663141-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eef6bff99fa91e0276deb2833934970f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L17-005
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L17-00
filingDate 2017-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18b371d5b6676d554ad690251b65a1f6
publicationDate 2019-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109663141-A
titleOfInvention A kind of double-edged eyelid suture
abstract The invention discloses a kind of double-edged eyelid sutures, component including following parts by weight: 60-70 parts of polypropylene, 3-8 parts of fimbrin, 4-9 parts of nakedflower beautyberry branchlet and leaf, 4-9 parts of nakedflower beautyberry branchlet and leaf, 6-10 parts of marginate rockbell herb, 1.2-1.8 parts of glycerol, 0.05-0.08 parts of hyaluronic acid, 10-15 parts of green English walnut fruit, 4-7 parts and Rose Mallow Root 6-10 parts of indian skullcap herb with root.With good blood compatibility and histocompatbility, no inflammation reaction, without rejection and adverse reaction in human body.
priorityDate 2017-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753

Total number of triples: 18.